for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Company News

BRIEF-Ozempic Approved In Canada For The Treatment Of Adults With Type 2 Diabetes

Jan 9 (Reuters) - Novo Nordisk:

* OZEMPIC® APPROVED IN CANADA FOR THE TREATMENT OF ADULTS WITH TYPE 2 DIABETES

* SAYS OZEMPIC DEMONSTRATED CLINICALLY MEANINGFUL IMPROVEMENTS IN BLOOD SUGAR AND BODY WEIGHT VERSUS COMPARATORS Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up